Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma

Sahil Khurana; Ajay Pal Singh; Ashok Kumar; Rajeev Nema

doi:10.7555/JBR.36.20220138

Volume 37 Issue 3

May 2023

Turn off MathJax

Article Contents

Article Navigation > The Journal of Biomedical Research > 2023 > 37(3): 225-228

Sahil Khurana, Ajay Pal Singh, Ashok Kumar, Rajeev Nema. Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma[J]. The Journal of Biomedical Research, 2023, 37(3): 225-228. doi: 10.7555/JBR.36.20220138

Citation:

Sahil Khurana, Ajay Pal Singh, Ashok Kumar, Rajeev Nema. Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma[J]. The Journal of Biomedical Research, 2023, 37(3): 225-228. doi: 10.7555/JBR.36.20220138

Citation:

PDF( 1999 KB)

Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma

doi: 10.7555/JBR.36.20220138

1.
All India Institute of Medical Sciences Bhopal, India 462021
2.
Department of Medicine, All India Institute of Medical Sciences Virbhadra Road, Rishikesh Uttarakhand, India 249201
3.
Department of Biochemistry, All India Institute of Medical Sciences AIIMS Bhopal, 462021
4.
Department of Oncology, 3B Black Bio Biotech India Ltd. 7-C, Industrial Area, Govindpura, Bhopal, India 462023

Received: 2022-06-06
Revised: 2022-08-03
Accepted: 2022-08-19

Published: 2022-11-10

Issue Date: 2023-05-28

Abstract

CLC number: R734.2, Document code: B
The authors reported no conflict of interests.

FullText(HTML)

References(4)

References

[1]	Clark SB, Alsubait S. Non small cell lung cancer[M]. Treasure Island (FL): StatPearls, 2021.
[2]	de Groot PM, Wu CC, Carter BW, et al. The epidemiology of lung cancer[J]. Transl Lung Cancer Res, 2018, 7(3): 220–233. doi: 10.21037/tlcr.2018.05.06
[3]	Győrffy B, Surowiak P, Budczies J, et al. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer[J]. PLoS One, 2013, 8(12): e82241. doi: 10.1371/journal.pone.0082241
[4]	Liu T, Zhu J, Du W et al. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma[J]. Respir Res, 2020, 21(1): 227. doi: 10.1186/s12931-020-01491-0